Placental insufficiency markers to assess the risk of non‐chromosomal genetic conditions in early‐onset fetal growth restriction

Documenti analoghi

• Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia
  di: E. Bonacina, et al.
  Pubblicazione: (2026)
• OP13.06: StopPRE trial: effect of aspirin discontinuation at 24–28 weeks on the trajectories of biophysical and biochemical markers
  di: M. Dalmau, et al.
  Pubblicazione: (2024)
• Cost–benefit analysis of first‐trimester pre‐eclampsia screening: comparison of multivariable Gaussian algorithm with and without placental growth factor
  di: E. Bonacina, et al.
  Pubblicazione: (2026)
• Deep learning assessment of fetal brain maturation on 3D ultrasound volumes in early‐onset fetal growth restriction
  di: L. Meijerink, et al.
  Pubblicazione: (2026)
• Re: Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late‐onset small fetuses with or without pre‐eclampsia
  di: M. Mendoza, et al.
  Pubblicazione: (2025)